The FDA has agreed to speed up a review of a rare disease drug developed by Stealth BioTherapeutics, a notable step after the ...

The FDA's controversial rejection of a skin cancer therapy from Replimune Group has prompted Krystal Biotech to shut down of ...

Soleno Therapeutics CEO responds to a 415-page short-seller report alleging safety issues tied to the company's newly ...

CVS Health will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, despite the medicine's proven effectiveness ...

Neuroscientists have long held that the brain reorganizes itself when a body part is amputated. A new study says that’s not ...

Correa and Bergman are co-chairs of the congressional Psychedelics Advancing Therapies (PATH) Caucus. Mercer is a Marine ...

Good morning. We've got a meaty issue for you today. In particular, I urge you to spend some time with Jason Mast's story. It's another heartbreaking ...

A new heart risk model had raised questions about who should take statins. A new study to "right-size" yields a similar ...

Provide your payment details. The free trial associated with this subscription will be appended to the standard duration of ...

New additions introduced by Faulkner and others include an AI scribe powered by Microsoft to rival products from health tech ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

After deaths and FDA setbacks, Sarepta abandoned LGMD gene therapy, leaving families desperate and patients without long-promised treatments.